Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Modulation of sensitivity and resistance to multikinase inhibitors by microenvironmental platelet factors in HCC
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 16, Issue 18, Pages 2773-2780
Publisher
Informa Healthcare
Online
2015-10-19
DOI
10.1517/14656566.2015.1101065
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer
- (2015) M Koti et al. BRITISH JOURNAL OF CANCER
- Macrophages and Therapeutic Resistance in Cancer
- (2015) Brian Ruffell et al. CANCER CELL
- Modulation of Regorafenib effects on HCC cell lines by epidermal growth factor
- (2015) Rosalba D’Alessandro et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Conditioning solid tumor microenvironment through inflammatory chemokines and S100 family proteins
- (2015) Mohd W. Nasser et al. CANCER LETTERS
- Molecular Pathways: Trafficking of Metabolic Resources in the Tumor Microenvironment
- (2015) I. L. Romero et al. CLINICAL CANCER RESEARCH
- Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer
- (2015) Nagaraj S. Nagathihalli et al. GASTROENTEROLOGY
- Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms?
- (2015) Brian K. P. Goh et al. JOURNAL OF SURGICAL ONCOLOGY
- Three-dimensional microenvironment confers enhanced sensitivity to doxorubicin by reducing p53-dependent induction of autophagy
- (2015) L R Gomes et al. ONCOGENE
- miR-494 promotes cell proliferation, migration and invasion, and increased sorafenib resistance in hepatocellular carcinoma by targeting PTEN
- (2015) KAI LIU et al. ONCOLOGY REPORTS
- The platelet-to-lymphocyte ratio predicts poor survival in patients with huge hepatocellular carcinoma that received transarterial chemoembolization
- (2015) Tong-Chun Xue et al. TUMOR BIOLOGY
- Role of Microenvironment in Resistance to Therapy in AML
- (2015) Yoko Tabe et al. Current Hematologic Malignancy Reports
- Modulation of Doxorubicin Mediated Growth Inhibition of Hepatocellular Carcinoma Cells by Platelet Lysates
- (2014) Maria Refolo et al. Anti-Cancer Agents in Medicinal Chemistry
- The tumour stromal features are associated with resistance to 5-FU-based chemoradiotherapy and a poor prognosis in patients with oral squamous cell carcinoma
- (2014) Yuichiro Matsuoka et al. APMIS
- Platelet extracts induce growth, migration and invasion in human hepatocellular carcinoma in vitro
- (2014) Brian I Carr et al. BMC CANCER
- Antagonism of Sorafenib and Regorafenib actions by platelet factors in hepatocellular carcinoma cell lines
- (2014) Rosalba D’Alessandro et al. BMC CANCER
- Involvement of platelets in extrahepatic metastasis of hepatocellular carcinoma
- (2014) Yuki Morimoto et al. HEPATOLOGY RESEARCH
- Protease-activated receptor-1 drives pancreatic cancer progression and chemoresistance
- (2014) Karla C.S. Queiroz et al. INTERNATIONAL JOURNAL OF CANCER
- VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE-1 study
- (2014) Mario Scartozzi et al. INTERNATIONAL JOURNAL OF CANCER
- Identification of Kinase Inhibitor Targets in the Lung Cancer Microenvironment by Chemical and Phosphoproteomics
- (2014) M. Gridling et al. MOLECULAR CANCER THERAPEUTICS
- Macro- and Micro-environmental Factors in Clinical Hepatocellular Cancer
- (2014) Petr Pancoska et al. SEMINARS IN ONCOLOGY
- Platelet-Related Phenotypic Patterns in Hepatocellular Carcinoma Patients
- (2014) Brian I. Carr et al. SEMINARS IN ONCOLOGY
- Direct TGF-β1 signaling between activated platelets and pancreatic cancer cells primes cisplatin insensitivity
- (2013) Hongxu Chen et al. CELL BIOLOGY INTERNATIONAL
- Thrombocytosis and Hepatocellular Carcinoma
- (2013) Brian I. Carr et al. DIGESTIVE DISEASES AND SCIENCES
- Recent progress in the identification of BRAF inhibitors as anti-cancer agents
- (2013) Hala Bakr El-Nassan EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer
- (2013) Hongping Xia et al. HEPATOLOGY
- Epidermal growth factor receptor inhibition attenuates liver fibrosis and development of hepatocellular carcinoma
- (2013) Bryan C. Fuchs et al. HEPATOLOGY
- The role of EGF-EGFR signalling pathway in hepatocellular carcinoma inflammatory microenvironment
- (2013) Peixin Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
- (2013) Giovanni Sitia et al. JOURNAL OF HEPATOLOGY
- Neutrophil and platelet-to-lymphocyte ratio as new predictors of dropout and recurrence after liver transplantation for hepatocellular cancer
- (2013) Quirino Lai et al. TRANSPLANT INTERNATIONAL
- Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
- (2012) A Gallardo et al. BRITISH JOURNAL OF CANCER
- Molecular Pathways: Involving Microenvironment Damage Responses in Cancer Therapy Resistance
- (2012) Y. Sun et al. CLINICAL CANCER RESEARCH
- Contrasted Outcomes to Gefitinib on Tumoral IGF1R Expression in Head and Neck Cancer Patients Receiving Postoperative Chemoradiation (GORTEC Trial 2004-02)
- (2012) J. Thariat et al. CLINICAL CANCER RESEARCH
- PDGF α receptor is a mediator for Cisplatin-induced Met expression
- (2012) Shinichiro Kina et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Tumor-platelet interaction in solid tumors
- (2012) Daniel Buergy et al. INTERNATIONAL JOURNAL OF CANCER
- Inhibition of IGF-IR increases chemosensitivity in human colorectal cancer cells through MRP-2 promoter suppression
- (2012) Ke Shen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Fluoro-Sorafenib (Regorafenib) effects on hepatoma cells: Growth inhibition, quiescence, and recovery
- (2012) Brian I. Carr et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Effects of low concentrations of Regorafenib and Sorafenib on human HCC cell AFP, migration, invasion, and growth in vitro
- (2012) Brian I. Carr et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Erlotinib and sorafenib in an orthotopic rat model of hepatocellular carcinoma
- (2012) Wolfgang Sieghart et al. JOURNAL OF HEPATOLOGY
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
- (2012) G. Sitia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fluoxetine synergys with anticancer drugs to overcome multidrug resistance in breast cancer cells
- (2012) Ting Zhou et al. TUMOR BIOLOGY
- Targeting platelet function to improve drug delivery
- (2012) Mélanie Demers et al. OncoImmunology
- Platelet Administration Via the Portal Vein Promotes Liver Regeneration in Rats After 70% Hepatectomy
- (2011) Ryota Matsuo et al. ANNALS OF SURGERY
- Celecoxib Inhibits Interleukin-6/Interleukin-6 Receptor-Induced JAK2/STAT3 Phosphorylation in Human Hepatocellular Carcinoma Cells
- (2011) Y. Liu et al. Cancer Prevention Research
- Increased Efficacy of Breast Cancer Chemotherapy in Thrombocytopenic Mice
- (2011) M. Demers et al. CANCER RESEARCH
- Targeting insulin-like growth factor axis in hepatocellular carcinoma
- (2011) Jennifer Wu et al. Journal of Hematology & Oncology
- Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations
- (2011) Xiaoli Chen et al. JOURNAL OF HEPATOLOGY
- Sorafenib: complexities of Raf-dependent and Raf-independent signaling are now unveiled
- (2011) Yasunobu Matsuda et al. Medical Molecular Morphology
- Molecularly targeted therapy in hepatocellular carcinoma
- (2010) Hung Huynh BIOCHEMICAL PHARMACOLOGY
- Differential Mechanisms of Acquired Resistance to Insulin-like Growth Factor-I Receptor Antibody Therapy or to a Small-Molecule Inhibitor, BMS-754807, in a Human Rhabdomyosarcoma Model
- (2010) F. Huang et al. CANCER RESEARCH
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Novel inhibitors in development for hepatocellular carcinoma
- (2010) Marcus Alexander Wörns et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells
- (2010) Jörg Schrader et al. HEPATOLOGY
- Regorafenib (BAY 73-4506): A new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity
- (2010) Scott M. Wilhelm et al. INTERNATIONAL JOURNAL OF CANCER
- O2 regulates stem cells through Wnt/β-catenin signalling
- (2010) Jolly Mazumdar et al. NATURE CELL BIOLOGY
- Beyond Clotting: The Powers of Platelets
- (2010) M. Leslie SCIENCE
- Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer cells
- (2009) Robert X.-D. Song et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Targeting insulin-like growth factor type 1 receptor in cancer therapy
- (2009) Francesco Atzori et al. Targeted Oncology
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- The role of platelet activation in tumor metastasis
- (2008) Lubor Borsig Expert Review of Anticancer Therapy
- Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
- (2008) Augusto Villanueva et al. GASTROENTEROLOGY
- Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma
- (2008) Ai-Wu Ke et al. HEPATOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started